The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Goodman Noah since 2026.
This trader's CIK number is 2060075.
At the time of last reporting, Goodman Noah was the Chief Business Officer of Kymera Therapeutics, Inc.. (stock ticker symbol KYMR).
Also see all insider trading activities at Kymera Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | KYMR | 0 | $0 | 10,264 | $898,428 | 2,500 | $52,625 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-04-10 | KYMR | Sale | 2,000 | 87.35 | 174,700 |
| 2026-04-09 | KYMR | Sale | 8,264 | 87.58 | 723,728 |
| 2026-04-09 | KYMR | Option Ex | 2,500 | 21.05 | 52,625 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goodman Noah (Chief Business Officer of Kymera Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.